| Pair Name | Resveratrol, BIBR1532 | ||
| Phytochemical Name | Resveratrol (PubChem CID: 445154 ) | ||
| Anticancer drug Name | BIBR1532 (PubChem CID: 9927531 ) | ||
| Structure of Phytochemical |
|
Download
2D
MOL
3D
MOL
|
|
| Structure of Anticancer Drug |
|
Download
2D
MOL
3D
MOL
|
|
| Pair Name | Resveratrol, BIBR1532 | |||
| Disease Info | [ICD-11: 2B90.Z] | Colon cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | CCAT1 | KEGG ID N.A. |
| Down-regulation | Expression | CRNDE | KEGG ID N.A. | |
| Down-regulation | Expression | PCAT1 | KEGG ID N.A. | |
| Down-regulation | Expression | PVT1 | KEGG ID N.A. | |
| Down-regulation | Expression | SNHG16 | KEGG ID N.A. | |
| In Vitro Model | HT-29 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0320 |
| Result | Resveratrol, BIBR1532, or their combination may have anti-proliferative effect on colorectal cancer cells through repressing expression of LncRNAs that are involved in progression of CRC. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs. Med Oncol. 2021 Nov 15;39(1):12. doi: 10.1007/s12032-021-01611-w. | Click |
